Ling‐Yen Chiu

662 total citations
17 papers, 551 citations indexed

About

Ling‐Yen Chiu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ling‐Yen Chiu has authored 17 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Ling‐Yen Chiu's work include Autophagy in Disease and Therapy (5 papers), Fungal Biology and Applications (4 papers) and Curcumin's Biomedical Applications (3 papers). Ling‐Yen Chiu is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Fungal Biology and Applications (4 papers) and Curcumin's Biomedical Applications (3 papers). Ling‐Yen Chiu collaborates with scholars based in Taiwan, United States and Ireland. Ling‐Yen Chiu's co-authors include Gwo‐Tarng Sheu, Jiunn‐Liang Ko, I‐Lun Hsin, Tsung‐Ying Yang, Ming‐Fang Wu, Tzu‐Chin Wu, Ming‐Shiou Jan, Gail M. Seigel, Chu‐Chyn Ou and Yen-Hsiang Huang and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Ling‐Yen Chiu

16 papers receiving 546 citations

Peers

Countries citing papers authored by Ling‐Yen Chiu

Since Specialization

Citations

This map shows the geographic impact of Ling‐Yen Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Yen Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Yen Chiu more than expected).

Fields of papers citing papers by Ling‐Yen Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Yen Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Yen Chiu. The network helps show where Ling‐Yen Chiu may publish in the future.

Co-authorship network of co-authors of Ling‐Yen Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Yen Chiu. A scholar is included among the top collaborators of Ling‐Yen Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Yen Chiu. Ling‐Yen Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Targeted inhibition of integrin αVβ3 induces cytotoxicity and suppresses migration ability in ovarian cancer cells and tumor spheroids 2025 ·International Journal of Medical Sciences ·I‐Lun Hsin, Ling‐Yen Chiu, Jiunn‐Liang Ko, Po-Hui Wang, Pei‐Ju Wu	0
2	Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor 2024 ·International Journal of Molecular Sciences ·Yen-Hsiang Huang, Ling‐Yen Chiu, Jeng‐Sen Tseng, Kuo-Hsuan Hsu, Chang‐Han Chen, Gwo‐Tarng Sheu, Tsung‐Ying Yang	14
3	Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation 2022 ·International Journal of Molecular Sciences ·Ming‐Fang Wu, Yen-Hsiang Huang, Ling‐Yen Chiu, Shur‐Hueih Cherng, Gwo‐Tarng Sheu, Tsung‐Ying Yang	51
4	<p>Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis</p> 2020 ·Cancer Management and Research ·(unknown), Ling‐Yen Chiu, Dom‐Gene Tu, Gwo‐Tarng Sheu, (unknown)	30
5	CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum 2020 ·British Journal of Cancer ·I‐Lun Hsin, Ling‐Yen Chiu, Chu‐Chyn Ou, Wenjun Wu, Gwo‐Tarng Sheu, Jiunn‐Liang Ko	21
6	Combination treatment of Src inhibitor Saracatinib with GMI, a Ganoderma microsporum immunomodulatory protein, induce synthetic lethality via autophagy and apoptosis in lung cancer cells 2020 ·Journal of Cellular Physiology ·Ling‐Yen Chiu, I‐Lun Hsin, Jen‐Ning Tsai, Chih‐Jung Chen, Chu‐Chyn Ou, Wenjun Wu, Gwo‐Tarng Sheu, Jiunn‐Liang Ko	13
7	Ni‐induced TGF‐β signaling promotes VEGF‐a secretion via integrin β3 upregulation 2019 ·Journal of Cellular Physiology ·Chih‐Hsien Wu, Jiunn‐Liang Ko, (unknown), Ling‐Yen Chiu, Yuting Kang, Yu‐Ping Hsiao	8
8	High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase 2017 ·Oncology Reports ·Wei‐Ting Kuo, Dom‐Gene Tu, Ling‐Yen Chiu, Gwo‐Tarng Sheu, Ming‐Fang Wu	10
9	Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells 2015 ·PLoS ONE ·Ling‐Yen Chiu, (unknown), Tsung‐Ying Yang, I‐Lun Hsin, Jiunn‐Liang Ko, Kan-Jen Tsai, Gwo‐Tarng Sheu	52
10	Effect of Folic Acid and VitaminB12on Pemetrexed Antifolate Chemotherapy in Nutrient Lung Cancer Cells 2013 ·BioMed Research International ·Tsung‐Ying Yang, Gee‐Chen Chang, Shih‐Lan Hsu, (unknown), Ling‐Yen Chiu, Gwo‐Tarng Sheu	20
11	Inhibition of lysosome degradation on autophagosome formation and responses to GMI, an immunomodulatory protein from Ganoderma microsporum 2012 ·British Journal of Pharmacology ·I‐Lun Hsin, Gwo‐Tarng Sheu, Ming‐Shiou Jan, Hai‐Lun Sun, Tzu‐Chin Wu, Ling‐Yen Chiu, Ko‐Huang Lue, Jiunn‐Liang Ko	58
12	GMI, an immunomodulatory protein fromGanoderma microsporum, induces autophagy in non-small cell lung cancer cells 2011 ·Autophagy ·I‐Lun Hsin, Chu‐Chyn Ou, Tzu‐Chin Wu, Ming‐Shiou Jan, Ming‐Fang Wu, Ling‐Yen Chiu, Ko‐Huang Lue, Jiunn‐Liang Ko	86
13	N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells 2010 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·I‐Lun Hsin, Gwo‐Tarng Sheu, Hung‐Hsuan Chen, Ling‐Yen Chiu, Horng‐Dar Wang, Hsiu‐Wen Chan, Chung‐Ping Hsu, Jiunn‐Liang Ko	41
14	Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010 ·I‐Lun Hsin, Gwo‐Tarng Sheu, Hung‐Hsuan Chen, Ling‐Yen Chiu, Horng‐Dar Wang, Hsiu‐Wen Chan, Chung‐Ping Hsu, Jiunn‐Liang Ko	4
15	L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines 2009 ·Toxicology Letters ·Ling‐Yen Chiu, Jiunn‐Liang Ko, Yi‐Ju Lee, Tsung‐Ying Yang, (unknown), Gwo‐Tarng Sheu	46
16	Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia 2007 ·Carcinogenesis ·Kam Tong Leung, (unknown), Shuming Sun, Paul K.S. Chan, Vincent E. C. Ooi, Ling‐Yen Chiu	44
17	Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. 2000 ·PubMed ·Gail M. Seigel, Ling‐Yen Chiu, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact